Advanced urothelial carcinoma: moving the field forward

Oncology (Williston Park). 2013 Mar;27(3):233-4, C3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Transitional Cell / drug therapy*
  • Humans
  • Molecular Targeted Therapy*
  • Neoplasm Proteins / antagonists & inhibitors*
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Neoplasm Proteins